Apogee Therapeutics, Inc. (APGE)
NASDAQ: APGE · USD
$134
+0.03 (+0.0%)· Recorded snapshot
Coverage state: Market snapshot only — no published research
Market snapshot recorded 2026-07-30 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.
On-demand research
Generate the first APGE analysis
Start the full research workflow when this ticker is ready in our data system.
| Market cap | 10.1B | |
|---|---|---|
| Net income (ttm) | -274.6M | |
| EPS (ttm) | -$4.32 | |
| Shares out | 75.1M | |
| Volume | 1,084,497 | |
| Beta | 0.32 | |
| Price target | $131 | -2.7% |
Market data
Price
Recent price action with selectable time range.
Financial snapshot
- Net income (ttm)
- -274.6M
- EPS (ttm)
- -$4.32
- Market cap
- 10.1B
Fair-value bridge
- Current price
- $134
Analyst consensus
Recommendation
Hold
Price target
$131
-2.7%
In the news
Latest news · APGE
Recent company headlines from major financial publishers.
Valuation
- Market cap
- 10.1B
- P/B
- 8.0x
Profitability
- ROE
- -28.5%
- ROA
- -19.0%
- ROIC
- -19.6%
Balance sheet
- Debt / equity
- 0.01
- Current ratio
- 32.59
- Quick ratio
- 32.39
Trading
- Beta
- 0.32
- Volume
- 1,084,497
- Dividend yield
- 0.0%